PMID- 11685098 OWN - NLM STAT- MEDLINE DCOM- 20020130 LR - 20191105 IS - 0883-5993 (Print) IS - 0883-5993 (Linking) VI - 16 IP - 4 DP - 2001 Oct TI - Severe alveolar proteinosis following chemotherapy for acute myeloid leukemia in a lung allograft recipient. PG - 307-9 AB - A 64-year-old man was diagnosed with acute myeloid leukemia (AML) 5 years following single lung transplantation performed for severe pulmonary hypertension from scleroderma. Chemotherapy for treatment of AML with fludarabine, cytosine arabinoside, G-CSF (FLAG) regimen was initiated. Despite intensive antibiotic treatment for a presumptive diagnosis of bacterial pneumonia, the patient developed acute respiratory failure and died before a complete cycle of chemotherapy could be administered. At autopsy, both native and allograft lungs showed widespread alveolar proteinosis that was determined as the main cause of acute respiratory failure. Alveolar proteinosis, a potentially treatable disease, should be considered in the radiologic differential diagnosis of diffuse lung disease in this clinical setting. FAU - Du, E Z AU - Du EZ AD - Department of Pathology, University of California San Diego, School of Medicine, San Diego, CA, USA. FAU - Yung, G L AU - Yung GL FAU - Le, D T AU - Le DT FAU - Masliah, E AU - Masliah E FAU - Yi, E S AU - Yi ES FAU - Friedman, P J AU - Friedman PJ LA - eng PT - Case Reports PT - Journal Article PL - United States TA - J Thorac Imaging JT - Journal of thoracic imaging JID - 8606160 RN - 04079A1RDZ (Cytarabine) RN - 143011-72-7 (Granulocyte Colony-Stimulating Factor) RN - FA2DM6879K (Vidarabine) RN - FLAG protocol SB - IM MH - Antineoplastic Combined Chemotherapy Protocols/*adverse effects MH - Cytarabine/*adverse effects MH - Diagnosis, Differential MH - Fatal Outcome MH - Granulocyte Colony-Stimulating Factor/*adverse effects MH - Humans MH - Leukemia, Myeloid, Acute/*complications/*drug therapy MH - Male MH - Middle Aged MH - Pulmonary Alveolar Proteinosis/*diagnostic imaging/*etiology MH - Tomography, X-Ray Computed MH - Vidarabine/*adverse effects/analogs & derivatives EDAT- 2001/10/31 10:00 MHDA- 2002/01/31 10:01 CRDT- 2001/10/31 10:00 PHST- 2001/10/31 10:00 [pubmed] PHST- 2002/01/31 10:01 [medline] PHST- 2001/10/31 10:00 [entrez] AID - 10.1097/00005382-200110000-00014 [doi] PST - ppublish SO - J Thorac Imaging. 2001 Oct;16(4):307-9. doi: 10.1097/00005382-200110000-00014.